Literature DB >> 650395

[Studies on heterocyclic compounds. XXXIV. Synthesis of furo[3,2-c]pyrazole derivatives. (2). Electrophilic substitution of 1,3-diphenylfuro[3,2-c]pyrazole (author's transl)].

S Yoshina, A Tanaka, S C Kuo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 650395     DOI： 10.1248/yakushi1947.98.2_204

Source DB:  PubMed          Journal:  Yakugaku Zasshi        ISSN： 0031-6903            Impact factor:   0.302


× No keyword cloud information.
  7 in total

1.  YC-1 potentiates nitric oxide-induced relaxation in guinea-pig trachea.

Authors:  T L Hwang; C C Wu; C M Teng
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

2.  Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme.

Authors:  A Friebe; G Schultz; D Koesling
Journal:  EMBO J       Date:  1996-12-16       Impact factor: 11.598

3.  YD-3, a novel inhibitor of protease-induced platelet activation.

Authors:  C C Wu; S W Huang; T L Hwang; S C Kuo; F Y Lee; C M Teng
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

4.  Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase.

Authors:  P Wohlfart; T Malinski; H Ruetten; U Schindler; W Linz; K Schoenafinger; H Strobel; G Wiemer
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

5.  Mechanism of anti-proliferation caused by YC-1, an indazole derivative, in cultured rat A10 vascular smooth-muscle cells.

Authors:  S M Yu; Z J Cheng; J H Guh; F Y Lee; S C Kuo
Journal:  Biochem J       Date:  1995-03-15       Impact factor: 3.857

6.  YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.

Authors:  C C Wu; F N Ko; S C Kuo; F Y Lee; C M Teng
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

7.  Antiproliferative effects of A02011-1, an adenylyl cyclase activator, in cultured vascular smooth muscle cells of rat.

Authors:  S M Yu; Z J Cheng; S C Kuo
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.